Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Innate Pharma Announces That It Will Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data At AACR 2024

Author: Benzinga Newsdesk | March 06, 2024 04:01am

IPH45 abstract selected for oral presentation at AACR Annual Meeting 2024
Preclinical data support further development of IPH45, a differentiated topoisomerase I inhibitor ADC targeting Nectin-4, which is progressing towards the clinic

Posted In: IPHA